This classification is supported by a literature review of patients with typical lesions for MS on magnetic resonance imaging (MRI) and MOG-IgG positivity by live or fixed CBA, who were found not to differ from what would be expected of clinically definite MS in terms of attack severity, treatment response, MRI evolution over time, and outcomes (74). Here, MOG is linked to myeloid sarcoma.